Omnicell

OMCL · NASDAQ

$36.49+$0.68 (+1.90%)TodayMarket closed · Oct 20, 5:31 PM ET

Prev close $35.81

OMCL analyst rating

BuyConsensus of 5 analysts over the last 12 months. 80% rate it a buy.

Strong buy0
Buy4
Hold1
Underperform0
Sell0

12-month price target · 9 analysts

Average $59.01 (+61.7% upside)

Low: $45.45
Now: $36.49
High: $73.50

Upgrades and downgrades

The latest rating actions, newest first

OMCL analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Piper Sandler	Aug 3, 2026	Maintains	Overweight	$55.00 → $45.00	39%
Wells Fargo	Jul 31, 2026	Maintains	Overweight	$55.00 → $50.00	48%
Keybanc	Jul 31, 2026	Maintains	Overweight	$70.00 → $65.00	35%
Keybanc	Apr 29, 2026	Maintains	Overweight	$60.00 → $70.00	35%
Wells Fargo	Apr 23, 2026	Maintains	Overweight	$52.00 → $55.00	48%
Piper Sandler	Feb 6, 2026	Maintains	Overweight	$63.00 → $49.00	39%
Benchmark	Feb 2, 2026	Maintains	Buy	$50.00 → $60.00	51%
Keybanc	Jan 8, 2026	Upgrade	Sector Weight → Overweight	$60.00	35%
Wells Fargo	Jan 5, 2026	Maintains	Overweight	$43.00 → $52.00	48%
B of A Securities	Dec 9, 2025	Maintains	Neutral	$36.00 → $46.00	58%

The case for and against

Updated Jul 28, 2026

Bull case

Omnicell is poised for strong growth in the coming years, driven by their innovative software and technology solutions that are transforming the pharmacy and nursing care delivery model. With a current P/E ratio of 11x NTM EBITDA estimates, Omnicell's stock is significantly undervalued compared to its historical average of 20x. The launch of their Titan XT series cabinets, which offers enhanced automation and AI features, is expected to drive incremental revenues and gain market share from their only major competitor, Pyxis. The recent FDA recall on Pyxis cabinets also presents a prime opportunity for Omnicell to convert customers and attract new ones. Despite some potential risks, such as economic recessions and cybersecurity concerns, the positive customer feedback and strong pipeline demand for their products bode well for Omnicell's future success. Therefore, this analyst has a favorable outlook on Omnicell's stock and has raised their price target to $70.

Bear case

Omnicell is experiencing strong bookings momentum and increased customer interest in their newer products, indicating potential for future revenue growth. However, their reliance on competitive conversions for a large portion of their bookings and the need to increase demo equipment could suggest that the market for their products is becoming more competitive. Additionally, their low profit margins and customer focus on cost-effective solutions may limit potential for significant profitability growth.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.